img

Global Transdermal Testosterone Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Transdermal Testosterone Market Insights, Forecast to 2034

Transdermal Testosterone contains testosterone. It is used for hormone replacement in men who are not able to produce enough testosterone (e.g., hypogonadism). This medication is absorbed through the skin, enters your bloodstream, and helps your body reach normal testosterone levels.
Global Transdermal Testosterone market is expected to reach to US$ 602 million in 2024, with a positive growth of %, compared with US$ 589 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Transdermal Testosterone industry is evaluated to reach US$ 923.9 million in 2029. The CAGR will be 7.4% during 2024 to 2029.
Globally, Transdermal Testosterone key manufacturers include AbbVie, Teva, Perrigo, Endo Pharmaceuticals, Acerus Pharmaceuticals, Lupin, Dr. Reddy's Laboratories, Upsher-Smith Laboratories and Allergan, etc. AbbVie, Teva, Perrigo are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Transdermal Testosterone were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Transdermal Testosterone market and estimated to attract more attentions from industry insiders and investors.
Transdermal Testosterone can be divided into Gel and Patch, etc. Gel is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Transdermal Testosterone is widely used in various fields, such as Primary Hypogonadism, Hypogonadotropic Hypogonadism and Late-Onset Hypogonadism,, etc. Primary Hypogonadism provides greatest supports to the Transdermal Testosterone industry development. In 2022, global % sales of Transdermal Testosterone went into Primary Hypogonadism filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Transdermal Testosterone market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Transdermal Testosterone market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


AbbVie
Teva
Perrigo
Endo Pharmaceuticals
Acerus Pharmaceuticals
Lupin
Dr. Reddy's Laboratories
Upsher-Smith Laboratories
Allergan
Cipla Inc.
Segment by Type
Gel
Patch

Segment by Application


Primary Hypogonadism
Hypogonadotropic Hypogonadism
Late-Onset Hypogonadism

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Transdermal Testosterone plant distribution, commercial date of Transdermal Testosterone, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Transdermal Testosterone introduction, etc. Transdermal Testosterone Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Transdermal Testosterone
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Transdermal Testosterone Product Introduction
1.2 Market by Type
1.2.1 Global Transdermal Testosterone Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Gel
1.2.3 Patch
1.3 Market by Application
1.3.1 Global Transdermal Testosterone Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Primary Hypogonadism
1.3.3 Hypogonadotropic Hypogonadism
1.3.4 Late-Onset Hypogonadism
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Transdermal Testosterone Sales Estimates and Forecasts 2018-2029
2.2 Global Transdermal Testosterone Revenue by Region
2.2.1 Global Transdermal Testosterone Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Transdermal Testosterone Revenue by Region (2018-2024)
2.2.3 Global Transdermal Testosterone Revenue by Region (2024-2029)
2.2.4 Global Transdermal Testosterone Revenue Market Share by Region (2018-2029)
2.3 Global Transdermal Testosterone Sales Estimates and Forecasts 2018-2029
2.4 Global Transdermal Testosterone Sales by Region
2.4.1 Global Transdermal Testosterone Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Transdermal Testosterone Sales by Region (2018-2024)
2.4.3 Global Transdermal Testosterone Sales by Region (2024-2029)
2.4.4 Global Transdermal Testosterone Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Transdermal Testosterone Sales by Manufacturers
3.1.1 Global Transdermal Testosterone Sales by Manufacturers (2018-2024)
3.1.2 Global Transdermal Testosterone Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Transdermal Testosterone in 2022
3.2 Global Transdermal Testosterone Revenue by Manufacturers
3.2.1 Global Transdermal Testosterone Revenue by Manufacturers (2018-2024)
3.2.2 Global Transdermal Testosterone Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Transdermal Testosterone Revenue in 2022
3.3 Global Key Players of Transdermal Testosterone, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Transdermal Testosterone Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Transdermal Testosterone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Transdermal Testosterone, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Transdermal Testosterone, Product Offered and Application
3.8 Global Key Manufacturers of Transdermal Testosterone, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Transdermal Testosterone Sales by Type
4.1.1 Global Transdermal Testosterone Historical Sales by Type (2018-2024)
4.1.2 Global Transdermal Testosterone Forecasted Sales by Type (2024-2029)
4.1.3 Global Transdermal Testosterone Sales Market Share by Type (2018-2029)
4.2 Global Transdermal Testosterone Revenue by Type
4.2.1 Global Transdermal Testosterone Historical Revenue by Type (2018-2024)
4.2.2 Global Transdermal Testosterone Forecasted Revenue by Type (2024-2029)
4.2.3 Global Transdermal Testosterone Revenue Market Share by Type (2018-2029)
4.3 Global Transdermal Testosterone Price by Type
4.3.1 Global Transdermal Testosterone Price by Type (2018-2024)
4.3.2 Global Transdermal Testosterone Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Transdermal Testosterone Sales by Application
5.1.1 Global Transdermal Testosterone Historical Sales by Application (2018-2024)
5.1.2 Global Transdermal Testosterone Forecasted Sales by Application (2024-2029)
5.1.3 Global Transdermal Testosterone Sales Market Share by Application (2018-2029)
5.2 Global Transdermal Testosterone Revenue by Application
5.2.1 Global Transdermal Testosterone Historical Revenue by Application (2018-2024)
5.2.2 Global Transdermal Testosterone Forecasted Revenue by Application (2024-2029)
5.2.3 Global Transdermal Testosterone Revenue Market Share by Application (2018-2029)
5.3 Global Transdermal Testosterone Price by Application
5.3.1 Global Transdermal Testosterone Price by Application (2018-2024)
5.3.2 Global Transdermal Testosterone Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Transdermal Testosterone Market Size by Type
6.1.1 US & Canada Transdermal Testosterone Sales by Type (2018-2029)
6.1.2 US & Canada Transdermal Testosterone Revenue by Type (2018-2029)
6.2 US & Canada Transdermal Testosterone Market Size by Application
6.2.1 US & Canada Transdermal Testosterone Sales by Application (2018-2029)
6.2.2 US & Canada Transdermal Testosterone Revenue by Application (2018-2029)
6.3 US & Canada Transdermal Testosterone Market Size by Country
6.3.1 US & Canada Transdermal Testosterone Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Transdermal Testosterone Sales by Country (2018-2029)
6.3.3 US & Canada Transdermal Testosterone Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Transdermal Testosterone Market Size by Type
7.1.1 Europe Transdermal Testosterone Sales by Type (2018-2029)
7.1.2 Europe Transdermal Testosterone Revenue by Type (2018-2029)
7.2 Europe Transdermal Testosterone Market Size by Application
7.2.1 Europe Transdermal Testosterone Sales by Application (2018-2029)
7.2.2 Europe Transdermal Testosterone Revenue by Application (2018-2029)
7.3 Europe Transdermal Testosterone Market Size by Country
7.3.1 Europe Transdermal Testosterone Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Transdermal Testosterone Sales by Country (2018-2029)
7.3.3 Europe Transdermal Testosterone Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Transdermal Testosterone Market Size
8.1.1 China Transdermal Testosterone Sales (2018-2029)
8.1.2 China Transdermal Testosterone Revenue (2018-2029)
8.2 China Transdermal Testosterone Market Size by Application
8.2.1 China Transdermal Testosterone Sales by Application (2018-2029)
8.2.2 China Transdermal Testosterone Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Transdermal Testosterone Market Size by Type
9.1.1 Asia Transdermal Testosterone Sales by Type (2018-2029)
9.1.2 Asia Transdermal Testosterone Revenue by Type (2018-2029)
9.2 Asia Transdermal Testosterone Market Size by Application
9.2.1 Asia Transdermal Testosterone Sales by Application (2018-2029)
9.2.2 Asia Transdermal Testosterone Revenue by Application (2018-2029)
9.3 Asia Transdermal Testosterone Sales by Region
9.3.1 Asia Transdermal Testosterone Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Transdermal Testosterone Revenue by Region (2018-2029)
9.3.3 Asia Transdermal Testosterone Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Transdermal Testosterone Market Size by Type
10.1.1 Middle East, Africa and Latin America Transdermal Testosterone Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Transdermal Testosterone Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Transdermal Testosterone Market Size by Application
10.2.1 Middle East, Africa and Latin America Transdermal Testosterone Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Transdermal Testosterone Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Transdermal Testosterone Sales by Country
10.3.1 Middle East, Africa and Latin America Transdermal Testosterone Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Transdermal Testosterone Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Transdermal Testosterone Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 AbbVie
11.1.1 AbbVie Company Information
11.1.2 AbbVie Overview
11.1.3 AbbVie Transdermal Testosterone Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 AbbVie Transdermal Testosterone Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AbbVie Recent Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Overview
11.2.3 Teva Transdermal Testosterone Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Teva Transdermal Testosterone Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Teva Recent Developments
11.3 Perrigo
11.3.1 Perrigo Company Information
11.3.2 Perrigo Overview
11.3.3 Perrigo Transdermal Testosterone Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Perrigo Transdermal Testosterone Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Perrigo Recent Developments
11.4 Endo Pharmaceuticals
11.4.1 Endo Pharmaceuticals Company Information
11.4.2 Endo Pharmaceuticals Overview
11.4.3 Endo Pharmaceuticals Transdermal Testosterone Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Endo Pharmaceuticals Transdermal Testosterone Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Endo Pharmaceuticals Recent Developments
11.5 Acerus Pharmaceuticals
11.5.1 Acerus Pharmaceuticals Company Information
11.5.2 Acerus Pharmaceuticals Overview
11.5.3 Acerus Pharmaceuticals Transdermal Testosterone Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Acerus Pharmaceuticals Transdermal Testosterone Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Acerus Pharmaceuticals Recent Developments
11.6 Lupin
11.6.1 Lupin Company Information
11.6.2 Lupin Overview
11.6.3 Lupin Transdermal Testosterone Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Lupin Transdermal Testosterone Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Lupin Recent Developments
11.7 Dr. Reddy's Laboratories
11.7.1 Dr. Reddy's Laboratories Company Information
11.7.2 Dr. Reddy's Laboratories Overview
11.7.3 Dr. Reddy's Laboratories Transdermal Testosterone Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Dr. Reddy's Laboratories Transdermal Testosterone Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Dr. Reddy's Laboratories Recent Developments
11.8 Upsher-Smith Laboratories
11.8.1 Upsher-Smith Laboratories Company Information
11.8.2 Upsher-Smith Laboratories Overview
11.8.3 Upsher-Smith Laboratories Transdermal Testosterone Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Upsher-Smith Laboratories Transdermal Testosterone Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Upsher-Smith Laboratories Recent Developments
11.9 Allergan
11.9.1 Allergan Company Information
11.9.2 Allergan Overview
11.9.3 Allergan Transdermal Testosterone Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Allergan Transdermal Testosterone Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Allergan Recent Developments
11.10 Cipla Inc.
11.10.1 Cipla Inc. Company Information
11.10.2 Cipla Inc. Overview
11.10.3 Cipla Inc. Transdermal Testosterone Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Cipla Inc. Transdermal Testosterone Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Cipla Inc. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Transdermal Testosterone Industry Chain Analysis
12.2 Transdermal Testosterone Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Transdermal Testosterone Production Mode & Process
12.4 Transdermal Testosterone Sales and Marketing
12.4.1 Transdermal Testosterone Sales Channels
12.4.2 Transdermal Testosterone Distributors
12.5 Transdermal Testosterone Customers
13 Market Dynamics
13.1 Transdermal Testosterone Industry Trends
13.2 Transdermal Testosterone Market Drivers
13.3 Transdermal Testosterone Market Challenges
13.4 Transdermal Testosterone Market Restraints
14 Key Findings in The Global Transdermal Testosterone Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Transdermal Testosterone Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Gel
Table 3. Major Manufacturers of Patch
Table 4. Global Transdermal Testosterone Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Transdermal Testosterone Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Transdermal Testosterone Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Transdermal Testosterone Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Transdermal Testosterone Revenue Market Share by Region (2018-2024)
Table 9. Global Transdermal Testosterone Revenue Market Share by Region (2024-2029)
Table 10. Global Transdermal Testosterone Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Transdermal Testosterone Sales by Region (2018-2024) & (K Units)
Table 12. Global Transdermal Testosterone Sales by Region (2024-2029) & (K Units)
Table 13. Global Transdermal Testosterone Sales Market Share by Region (2018-2024)
Table 14. Global Transdermal Testosterone Sales Market Share by Region (2024-2029)
Table 15. Global Transdermal Testosterone Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Transdermal Testosterone Sales Share by Manufacturers (2018-2024)
Table 17. Global Transdermal Testosterone Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Transdermal Testosterone Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Transdermal Testosterone, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Transdermal Testosterone Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Transdermal Testosterone Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Transdermal Testosterone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Testosterone as of 2022)
Table 23. Global Key Manufacturers of Transdermal Testosterone, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Transdermal Testosterone, Product Offered and Application
Table 25. Global Key Manufacturers of Transdermal Testosterone, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Transdermal Testosterone Sales by Type (2018-2024) & (K Units)
Table 28. Global Transdermal Testosterone Sales by Type (2024-2029) & (K Units)
Table 29. Global Transdermal Testosterone Sales Share by Type (2018-2024)
Table 30. Global Transdermal Testosterone Sales Share by Type (2024-2029)
Table 31. Global Transdermal Testosterone Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Transdermal Testosterone Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Transdermal Testosterone Revenue Share by Type (2018-2024)
Table 34. Global Transdermal Testosterone Revenue Share by Type (2024-2029)
Table 35. Transdermal Testosterone Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Transdermal Testosterone Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Transdermal Testosterone Sales by Application (2018-2024) & (K Units)
Table 38. Global Transdermal Testosterone Sales by Application (2024-2029) & (K Units)
Table 39. Global Transdermal Testosterone Sales Share by Application (2018-2024)
Table 40. Global Transdermal Testosterone Sales Share by Application (2024-2029)
Table 41. Global Transdermal Testosterone Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Transdermal Testosterone Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Transdermal Testosterone Revenue Share by Application (2018-2024)
Table 44. Global Transdermal Testosterone Revenue Share by Application (2024-2029)
Table 45. Transdermal Testosterone Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Transdermal Testosterone Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Transdermal Testosterone Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Transdermal Testosterone Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Transdermal Testosterone Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Transdermal Testosterone Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Transdermal Testosterone Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Transdermal Testosterone Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Transdermal Testosterone Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Transdermal Testosterone Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Transdermal Testosterone Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Transdermal Testosterone Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Transdermal Testosterone Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Transdermal Testosterone Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Transdermal Testosterone Sales by Country (2024-2029) & (K Units)
Table 60. Europe Transdermal Testosterone Sales by Type (2018-2024) & (K Units)
Table 61. Europe Transdermal Testosterone Sales by Type (2024-2029) & (K Units)
Table 62. Europe Transdermal Testosterone Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Transdermal Testosterone Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Transdermal Testosterone Sales by Application (2018-2024) & (K Units)
Table 65. Europe Transdermal Testosterone Sales by Application (2024-2029) & (K Units)
Table 66. Europe Transdermal Testosterone Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Transdermal Testosterone Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Transdermal Testosterone Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Transdermal Testosterone Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Transdermal Testosterone Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Transdermal Testosterone Sales by Country (2018-2024) & (K Units)
Table 72. Europe Transdermal Testosterone Sales by Country (2024-2029) & (K Units)
Table 73. China Transdermal Testosterone Sales by Type (2018-2024) & (K Units)
Table 74. China Transdermal Testosterone Sales by Type (2024-2029) & (K Units)
Table 75. China Transdermal Testosterone Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Transdermal Testosterone Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Transdermal Testosterone Sales by Application (2018-2024) & (K Units)
Table 78. China Transdermal Testosterone Sales by Application (2024-2029) & (K Units)
Table 79. China Transdermal Testosterone Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Transdermal Testosterone Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Transdermal Testosterone Sales by Type (2018-2024) & (K Units)
Table 82. Asia Transdermal Testosterone Sales by Type (2024-2029) & (K Units)
Table 83. Asia Transdermal Testosterone Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Transdermal Testosterone Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Transdermal Testosterone Sales by Application (2018-2024) & (K Units)
Table 86. Asia Transdermal Testosterone Sales by Application (2024-2029) & (K Units)
Table 87. Asia Transdermal Testosterone Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Transdermal Testosterone Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Transdermal Testosterone Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Transdermal Testosterone Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Transdermal Testosterone Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Transdermal Testosterone Sales by Region (2018-2024) & (K Units)
Table 93. Asia Transdermal Testosterone Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Transdermal Testosterone Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Transdermal Testosterone Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Transdermal Testosterone Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Transdermal Testosterone Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Transdermal Testosterone Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Transdermal Testosterone Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Transdermal Testosterone Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Transdermal Testosterone Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Transdermal Testosterone Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Transdermal Testosterone Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Transdermal Testosterone Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Transdermal Testosterone Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Transdermal Testosterone Sales by Country (2024-2029) & (K Units)
Table 107. AbbVie Company Information
Table 108. AbbVie Description and Major Businesses
Table 109. AbbVie Transdermal Testosterone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. AbbVie Transdermal Testosterone Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. AbbVie Recent Developments
Table 112. Teva Company Information
Table 113. Teva Description and Major Businesses
Table 114. Teva Transdermal Testosterone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Teva Transdermal Testosterone Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Teva Recent Developments
Table 117. Perrigo Company Information
Table 118. Perrigo Description and Major Businesses
Table 119. Perrigo Transdermal Testosterone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Perrigo Transdermal Testosterone Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Perrigo Recent Developments
Table 122. Endo Pharmaceuticals Company Information
Table 123. Endo Pharmaceuticals Description and Major Businesses
Table 124. Endo Pharmaceuticals Transdermal Testosterone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Endo Pharmaceuticals Transdermal Testosterone Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Endo Pharmaceuticals Recent Developments
Table 127. Acerus Pharmaceuticals Company Information
Table 128. Acerus Pharmaceuticals Description and Major Businesses
Table 129. Acerus Pharmaceuticals Transdermal Testosterone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Acerus Pharmaceuticals Transdermal Testosterone Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Acerus Pharmaceuticals Recent Developments
Table 132. Lupin Company Information
Table 133. Lupin Description and Major Businesses
Table 134. Lupin Transdermal Testosterone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. Lupin Transdermal Testosterone Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Lupin Recent Developments
Table 137. Dr. Reddy's Laboratories Company Information
Table 138. Dr. Reddy's Laboratories Description and Major Businesses
Table 139. Dr. Reddy's Laboratories Transdermal Testosterone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. Dr. Reddy's Laboratories Transdermal Testosterone Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Dr. Reddy's Laboratories Recent Developments
Table 142. Upsher-Smith Laboratories Company Information
Table 143. Upsher-Smith Laboratories Description and Major Businesses
Table 144. Upsher-Smith Laboratories Transdermal Testosterone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 145. Upsher-Smith Laboratories Transdermal Testosterone Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Upsher-Smith Laboratories Recent Developments
Table 147. Allergan Company Information
Table 148. Allergan Description and Major Businesses
Table 149. Allergan Transdermal Testosterone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 150. Allergan Transdermal Testosterone Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Allergan Recent Developments
Table 152. Cipla Inc. Company Information
Table 153. Cipla Inc. Description and Major Businesses
Table 154. Cipla Inc. Transdermal Testosterone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 155. Cipla Inc. Transdermal Testosterone Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Cipla Inc. Recent Developments
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Transdermal Testosterone Distributors List
Table 160. Transdermal Testosterone Customers List
Table 161. Transdermal Testosterone Market Trends
Table 162. Transdermal Testosterone Market Drivers
Table 163. Transdermal Testosterone Market Challenges
Table 164. Transdermal Testosterone Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Transdermal Testosterone Product Picture
Figure 2. Global Transdermal Testosterone Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Transdermal Testosterone Market Share by Type in 2022 & 2029
Figure 4. Gel Product Picture
Figure 5. Patch Product Picture
Figure 6. Global Transdermal Testosterone Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Transdermal Testosterone Market Share by Application in 2022 & 2029
Figure 8. Primary Hypogonadism
Figure 9. Hypogonadotropic Hypogonadism
Figure 10. Late-Onset Hypogonadism
Figure 11. Transdermal Testosterone Report Years Considered
Figure 12. Global Transdermal Testosterone Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Transdermal Testosterone Revenue 2018-2029 (US$ Million)
Figure 14. Global Transdermal Testosterone Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Transdermal Testosterone Revenue Market Share by Region (2018-2029)
Figure 16. Global Transdermal Testosterone Sales 2018-2029 ((K Units)
Figure 17. Global Transdermal Testosterone Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Transdermal Testosterone Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Transdermal Testosterone Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Transdermal Testosterone Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Transdermal Testosterone Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Transdermal Testosterone Sales YoY (2018-2029) & (K Units)
Figure 23. China Transdermal Testosterone Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Transdermal Testosterone Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Transdermal Testosterone Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Transdermal Testosterone Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Transdermal Testosterone Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Transdermal Testosterone Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Transdermal Testosterone in the World: Market Share by Transdermal Testosterone Revenue in 2022
Figure 30. Global Transdermal Testosterone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Transdermal Testosterone Sales Market Share by Type (2018-2029)
Figure 32. Global Transdermal Testosterone Revenue Market Share by Type (2018-2029)
Figure 33. Global Transdermal Testosterone Sales Market Share by Application (2018-2029)
Figure 34. Global Transdermal Testosterone Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Transdermal Testosterone Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Transdermal Testosterone Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Transdermal Testosterone Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Transdermal Testosterone Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Transdermal Testosterone Revenue Share by Country (2018-2029)
Figure 40. US & Canada Transdermal Testosterone Sales Share by Country (2018-2029)
Figure 41. U.S. Transdermal Testosterone Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Transdermal Testosterone Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Transdermal Testosterone Sales Market Share by Type (2018-2029)
Figure 44. Europe Transdermal Testosterone Revenue Market Share by Type (2018-2029)
Figure 45. Europe Transdermal Testosterone Sales Market Share by Application (2018-2029)
Figure 46. Europe Transdermal Testosterone Revenue Market Share by Application (2018-2029)
Figure 47. Europe Transdermal Testosterone Revenue Share by Country (2018-2029)
Figure 48. Europe Transdermal Testosterone Sales Share by Country (2018-2029)
Figure 49. Germany Transdermal Testosterone Revenue (2018-2029) & (US$ Million)
Figure 50. France Transdermal Testosterone Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Transdermal Testosterone Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Transdermal Testosterone Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Transdermal Testosterone Revenue (2018-2029) & (US$ Million)
Figure 54. China Transdermal Testosterone Sales Market Share by Type (2018-2029)
Figure 55. China Transdermal Testosterone Revenue Market Share by Type (2018-2029)
Figure 56. China Transdermal Testosterone Sales Market Share by Application (2018-2029)
Figure 57. China Transdermal Testosterone Revenue Market Share by Application (2018-2029)
Figure 58. Asia Transdermal Testosterone Sales Market Share by Type (2018-2029)
Figure 59. Asia Transdermal Testosterone Revenue Market Share by Type (2018-2029)
Figure 60. Asia Transdermal Testosterone Sales Market Share by Application (2018-2029)
Figure 61. Asia Transdermal Testosterone Revenue Market Share by Application (2018-2029)
Figure 62. Asia Transdermal Testosterone Revenue Share by Region (2018-2029)
Figure 63. Asia Transdermal Testosterone Sales Share by Region (2018-2029)
Figure 64. Japan Transdermal Testosterone Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Transdermal Testosterone Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Transdermal Testosterone Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Transdermal Testosterone Revenue (2018-2029) & (US$ Million)
Figure 68. India Transdermal Testosterone Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Transdermal Testosterone Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Transdermal Testosterone Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Transdermal Testosterone Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Transdermal Testosterone Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Transdermal Testosterone Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Transdermal Testosterone Sales Share by Country (2018-2029)
Figure 75. Brazil Transdermal Testosterone Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Transdermal Testosterone Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Transdermal Testosterone Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Transdermal Testosterone Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Transdermal Testosterone Revenue (2018-2029) & (US$ Million)
Figure 80. Transdermal Testosterone Value Chain
Figure 81. Transdermal Testosterone Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries